Aprea Therapeutics, Inc.
SEC Filing List
APRE CIK: 0001781983
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | SHARTSIS FRIESE LLP /fa | 08/13/2026 | |||
| 8-K | Current report filing | Aprea Therapeutics, Inc. | Toppan Merrill/FA | 08/12/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Aprea Therapeutics, Inc. | Toppan Merrill/FA | 08/12/2026 | |
| 8-K | Current report filing | Aprea Therapeutics, Inc. | Toppan Merrill/FA | 07/23/2026 | |
| 4 | Statement of changes in beneficial owner... | Grissinger Michael | Toppan Merrill/FA | 06/17/2026 | |
| 4 | Statement of changes in beneficial owner... | Pamukcu Rifat | Toppan Merrill/FA | 06/17/2026 | |
| 4 | Statement of changes in beneficial owner... | Bizzari Jean-pierre | Toppan Merrill/FA | 06/17/2026 | |
| 4 | Statement of changes in beneficial owner... | Seizinger Bernd R. | Toppan Merrill/FA | 06/17/2026 | |
| 4 | Statement of changes in beneficial owner... | Duey Marc | Toppan Merrill/FA | 06/17/2026 | |
| 4 | Statement of changes in beneficial owner... | Gruia Gabriela | Toppan Merrill/FA | 06/17/2026 | |
| No record found. | |||||
| Load More | |||||
